Status:
RECRUITING
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
Lead Sponsor:
Lahey Clinic
Conditions:
Urothelial Cancer
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be he...
Detailed Description
Bladder cancer is one of the most common malignancies worldwide. The rate of occurrence of these tumors is highest in the developed countries, ranking as the sixth most frequent neoplasm. Approximatel...
Eligibility Criteria
Inclusion
- Patients scheduled to have a nephroureterectomy, cystectomy, cytoscopy (newly diagnosed bladder cancer and those with recurrent disease in follow up)
- Control Group: No known evidence of bladder cancer-one urine sample
- \> than 18 years of age
Exclusion
- \< than 18 years of age
Key Trial Info
Start Date :
September 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2028
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00872495
Start Date
September 1 2002
End Date
November 1 2028
Last Update
December 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lahey Clinic, Inc.
Burlington, Massachusetts, United States, 01805